SOURCE: Alkermes
DESCRIPTION:
A new study from the National Institute on Alcohol Abuse and Alcoholism shows alcohol-related deaths increased by 25% in 2020 and remained elevated in 2021. As Alcohol Awareness Month comes to a close, learn more about the latest data on alcohol use: https://bit.ly/36spjad
About Alkermes
Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.
KEYWORDS: NASDAQ:ALKS, Alkermes, Alcohol related deaths